Author: biocytogen

AACR Virtual Annual Meeting II (Poster Session)

June 3, 2020

The AACR Foundation is the philanthropic arm of the American Association for Cancer Research (AACR). The Foundation supports the groundbreaking work of the AACR and its more than 47,000 members on the front lines of the global effort to eradicate cancer. The AACR Annual Meeting program covers the latest discoveries across the spectrum of cancer […]

Read More

Biocytogen is Featured in GEN’s Immunotherapy and Cancer Supplement Issue

April 10, 2020

Developing animal models for immunotherapy is often difficult due to the complexity of the immune system and tumor biology. Showcased in April’s GEN Magazine, Biocytogen presents a line of target-humanized mice models, covering a growing portfolio of immune checkpoints and cytokines alongside its flagship RenMab fully human antibody mouse. Biocytogen has also developed the immunodeficient […]

Read More

Biocytogen CEO’s Response During COVID-19 Pandemic

April 8, 2020

Dear Valued Customer, The COVID-19 global outbreak has undoubtedly brought upon difficult times for individuals, families, and businesses around the world. Many of us have never experienced an interruption of life at this scale. Amid this turmoil, I wanted to provide some status updates. Today, I am very glad to let you know that all […]

Read More

Biocytogen Announces Dr. Zhaoxue (Luke) Yu as Global Head of Preclinical Pharmacology

April 2, 2020

On March 31st, Biocytogen announced Dr. Zhaoxue (Luke) Yu as our Global Head of Preclinical Pharmacology. As our global preclinical pharmacology team leader, Dr. Yu is dedicated to furthering Biocytogen’s innovative antibody discovery platform and serving as our liaison person for strategic partnerships between Biocytogen and external collaborators. Dr. Yu brings more than 15 years […]

Read More

Webinar: In Vivo vs. In Vitro Therapeutic Antibody Discovery

March 23, 2020

Date: April 16th, 2020 | 11am EST Presenter: Lei Chen,  Ph.D. Senior Director of Antibody Discovery of Biocytogen The event has passed. Now, you can view the Webinar on YouTube. About the webinar in vivo antibody discovery using transgenic/humanized mice is of rising importance for the antibody community as it offers a multitude of benefits over in […]

Read More

Gene Targeting Service Verified with Industry-leading Quality Control Measures

March 12, 2020

  At Biocytogen, we take pride in our quality control measures when we target and edit genes for our mouse models and drug development endeavors. From preventing potentially disastrous results before they occur to instituting reliable, tried-and-true protocols, proper attention to quality control when gene-editing can save clients both time and resources. For example, based […]

Read More

GEN Magazine Mentions Biocytogen and Its Humanized Mice Model

March 6, 2020

Showcased in GEN Magazine’s March issue, Biocytogen speaks about the current state and imminent future of animal models, specifically on the humanization of mouse models for complex drug development challenges. Senior vice president of Biocytogen and CEO of Biocytogen Boston Qingcong Lin, PhD is featured alongside executives at Charles River Laboratories, Taconic Biosciences, Jackson Laboratory, […]

Read More

Knock In and Knock Out Mice as Powerful Disease Models

March 3, 2020

Why Do We Care About Gene-edited Mice? The generation of knockout and knock-in animal models has allowed not only disease research but also the development of disease-fighting drugs. The Nobel Prize for Physiology and Medicine recognized Evans, Smithies, and Capecchi for their joint effort in creating the first knockout mouse over two decades ago in […]

Read More

Peptalk 2020: The Protein Science Week

January 13, 2020

Location: Hilton San Diego Bayfront, San Diego, CA Dates: January 20-24, 2020 Booth: #424 RenMab™ Mouse: a leading platform for fully human antibody generation Speaker: Benny Yang, Chief Scientific Officer & Director of Antibody Discovery of Biocytogen Time: January 22 at 12:15 pm Track: Lead and Candidate Selection for Therapeutic Proteins Presentation Abstract: Biocytogen has […]

Read More

Nature Research Webcast: Accelerating therapeutic antibody discovery with fully human antibody mice

November 26, 2019

Date: December 10, 2019 Time: 8am PST / 11am EST / 4pm GMT / 5pm CET Register Now Overview: Production of fully human antibody is a critical step in the antibody discovery process. In many cases, hybridoma with genetically modified animals or post-optimization humanization are often employed to generate humanized antibodies. Amid the laborious procedures, some major […]

Read More

Back to top